Filing Flows › Theravance Biopharma (TBPH) › How it makes money
How Theravance Biopharma (TBPH) makes money
Theravance Biopharma (TBPH) made $20.7M of revenue in the second quarter 2026 (Q2 2026), -21% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $20.7M | 100.0% |
| Income tax | $1.1M | 5.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $20.7M | -21% |
| Q1 2026 | $17.7M | +15% |
| Q4 2025 | $45.9M | +145% |
| Q3 2025 | $20.0M | +18% |
| Q2 2025 | $26.2M | +84% |
| Q1 2025 | $15.4M | +6% |
| Q4 2024 | $18.8M | +7% |
From Theravance Biopharma's 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Theravance Biopharma make money?
Theravance Biopharma (TBPH) made $20.7M of revenue in the second quarter 2026 (Q2 2026), -21% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.